Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Hellenic Cooperative Oncology Group
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Hellenic Cooperative Oncology Group
ClinicalTrials.gov Identifier:
NCT01855724
First received: May 14, 2013
Last updated: December 30, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)